Inventor · Paris, FR

Jean-Gerard Guillet

13Patents
9h-index
32Co-inventors
72Inventor score

Filing activity: May 3, 1985 → Oct 27, 2010

Most-cited inventions

PatentTitleAreaCited byStatus
US5751839A Apparatus and process for the detection and counting of rarely occurring mammalian cells Physics 43 Expired
US5019384A Immunonodulating compositions and their use Chemistry; Metallurgy 32 Expired
US7476386B1 Mixed lipopeptide micelles for inducing an immune response Emerging Cross-Sectional Technologies 24 Expired
US7288258B2 Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination Chemistry; Metallurgy 19 Expired
US4859595A Method for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby Emerging Cross-Sectional Technologies 15 Expired
US6783763B1 Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines Chemistry; Metallurgy 14 Expired
US4780407A Monoclonal antibodies to legionella, a process for their preparation and their use in the determination of legionella pneumophila Emerging Cross-Sectional Technologies 9 Expired
US7488791B2 Mixture of peptides derived from E6 and/or E7 papillomavirus proteins and uses thereof Emerging Cross-Sectional Technologies 9 Expired
US6683052B1 Lipopeptides containing an interferon-&ggr; fragment, and uses thereof in pharmaceutical compositions Emerging Cross-Sectional Technologies 9 Expired
US7872098B1 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Human Necessities 2 Active
US8932599B2 Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines Chemistry; Metallurgy 0 Active
US8475800B2 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Human Necessities 0 Active
US6333359A Regulation of cellular apoptosis using modulators of .beta.-AR receptors Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.